KIA
Kopp Investment Advisors’s BioMarin Pharmaceuticals BMRN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-10,015
| Closed | -$812K | – | 61 |
|
|
2018
Q1 | $812K | Hold |
10,015
| – | – | 0.83% | 38 |
|
|
2017
Q4 | $893K | Sell |
10,015
-995
| -9% | -$88.7K | 0.89% | 37 |
|
|
2017
Q3 | $1.03M | Sell |
11,010
-129
| -1% | -$12K | 0.94% | 34 |
|
|
2017
Q2 | $1.01M | Sell |
11,139
-44
| -0.4% | -$4K | 0.91% | 31 |
|
|
2017
Q1 | $982K | Buy |
11,183
+85
| +0.8% | +$7.46K | 0.96% | 33 |
|
|
2016
Q4 | $919K | Sell |
11,098
-286
| -3% | -$23.7K | 0.97% | 33 |
|
|
2016
Q3 | $1.05M | Sell |
11,384
-313
| -3% | -$29K | 1.04% | 28 |
|
|
2016
Q2 | $910K | Sell |
11,697
-273
| -2% | -$21.2K | 0.48% | 39 |
|
|
2016
Q1 | $987K | Buy |
11,970
+3,246
| +37% | +$268K | 0.54% | 34 |
|
|
2015
Q4 | $914K | Buy |
+8,724
| New | +$914K | 0.45% | 38 |
|
|
2013
Q4 | – | Sell |
-11,691
| Closed | -$844K | – | 68 |
|
|
2013
Q3 | $844K | Sell |
11,691
-1,646
| -12% | -$119K | 0.31% | 65 |
|
|
2013
Q2 | $743K | Buy |
+13,337
| New | +$743K | 0.29% | 79 |
|